Le produit a bien été ajouté au panier.

discount label
H-TAFTIPSI-OH
Vue en 3D

Biosynth logo

H-TAFTIPSI-OH

Ref. 3D-PP46850

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Livraison estimée en/au États-Unis, le vendredi 27 décembre 2024

Informations sur le produit

Nom :
H-TAFTIPSI-OH
Synonymes :
  • NH2-Thr-Ala-Phe-Thr-Ile-Pro-Ser-Ile-OH
Description :

Peptide H-TAFTIPSI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TAFTIPSI-OH include the following: Multilayered defense in HLA-B51-Associated HIV viral control YH Zhang, YC Peng, HP Yan, K Xu, M Saito - The Journal of , 2011 - journals.aai.orghttps://journals.aai.org/jimmunol/article/187/2/684/38834 Distinct HIV-1 escape patterns selected by cytotoxic T cells with identical epitope specificity Y Yagita, N Kuse, K Kuroki, H Gatanaga - Journal of , 2013 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02572-12 Adaptation of HIV-1 to human leukocyte antigen class I Y Kawashima, K Pfafferott, J Frater , P Matthews - Nature, 2009 - nature.comhttps://www.nature.com/articles/nature07746 Strong Human Endogenous RSTCR Are - J. Virol, 2011 - academia.eduhttps://www.academia.edu/download/44498147/Strong_human_endogenous_retrovirus-speci20160406-12165-kymueq.pdf HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates RB Jones , KE Garrison , S Mujib - The Journal of , 2012 - Am Soc Clin Investighttps://www.jci.org/articles/30670 Longitudinal analysis of an HLA-B* 51-restricted epitope in integrase reveals immune escape in early HIV-1 infection N Yager, N Robinson, H Brown, P Flanagan , J Frater - AIDS, 2013 - journals.lww.comhttps://journals.lww.com/aidsonline/fulltext/2013/01280/longitudinal_analysis_of_an_hla_b_51_restricted.2.aspx Monitoring HIV-specific CD8+ T cell responses by intracellular cytokine production MR Betts , JP Casazza, RA Koup - Immunology Letters, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165247801002735 Putative Immunodominant Human Immunodeficiency Virus-Specific CD8+ T-Cell Responses Cannot Be Predicted by Major Histocompatibility Complex Class I MR Betts , JP Casazza, BA Patterson, S Waldrop - Journal of , 2000 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.74.19.9144-9151.2000 Nonstandard Peptide Binding Revealed by M Takiguchi, DI Stuart , EY Jones , K Maenaka - J , 2000 - researchgate.nethttps://www.researchgate.net/profile/David_Stuart4/publication/12346091_Nonstandard_Peptide_Binding_Revealed_by_Crystal_Structures_of_HLA-B5101_Complexed_with_HIV_Immunodominant_Epitopes/links/56d4296608ae2ea08cf8db44/Nonstandard-Peptide-Binding-Revealed-by-Crystal-Structures-of-HLA-B5101-Complexed-with-HIV-Immunodominant-Epitopes.pdf Cytotoxic T-lymphocyte responses to HIV-1 reverse transcriptase L Menendez-Arias , A MAS , E DOMINGO - Viral immunology, 1998 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/vim.1998.11.167 A high-throughput MALDI-TOF MS biochemical screen for small molecule inhibitors of the antigen aminopeptidase ERAP1 L Muller, AK Burton, CL Tayler, JE Rowedder - SLAS Discovery, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S247255522213707X Identification of cross-clade CTL epitopes in HIV-1 clade A/E-infected individuals by using the clade B overlapping peptides K Watanabe, H Murakoshi, Y Tamura, M Koyanagi - Microbes and , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1286457913001548 Nonstandard peptide binding revealed by crystal structures of HLA-B* 5101 complexed with HIV immunodominant epitopes K Maenaka, T Maenaka, H Tomiyama - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/165/6/3260/69809 Immunologic pressure within class I-restricted cognate human immunodeficiency virus epitopes during highly active antiretroviral therapy JP Casazza, MR Betts , BJ Hill, JM Brenchley - Journal of , 2005 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.79.6.3653-3663.2005 Targeting the regulatory site of ER aminopeptidase 1 leads to the discovery of a natural product modulator of antigen presentation J Liddle, JP Hutchinson, S Kitchen - Journal of Medicinal , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.9b02123 Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface. DP wOOLEY, P KT, T RJ, P CC, B MA - Aids, 2000 - search.proquest.comhttps://search.proquest.com/openview/67df1d0818c025701edfd260f85c5c2c/1?pq-origsite=gscholar&cbl=32744 Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection D SenGupta, R Tandon , RGS Vieira - Journal of , 2011 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.00179-11 Molecular basis of a dominant T cell response to an HIV reverse transcriptase 8-mer epitope presented by the protective allele HLA-B* 51: 01 C Motozono, N Kuse, X Sun , PJ Rizkallah - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/192/7/3428/108297 15. Peptide Motif of HLA-B* 5101 and the Linkage To Behaca§et's Disease C LEMMEL, HG RAMMENSEE - Immunology of Beh's , 2003 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=gqMp1w-AbbUC&oi=fnd&pg=PA127&dq=(%22NH2-Thr-Ala-Phe-Thr-Ile-Pro-Ser-Ile-OH%22+OR+%22TAFTIPSI%22+OR+%22H-TAFTIPSI-OH%22)+AND+peptide&ots=rx0-3VNeb_&sig=W_MzoZqUvaGP98nqgJsfijUlb4U 15. Peptide Motif of HLA-B* 5101 and the Linkage To Behaca§et's Disease C LEMMEL, HG RAMMENSEE - Immunology of Beh's , 2003 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=gqMp1w-AbbUC&oi=fnd&pg=PA127&dq=(%22NH2-Thr-Ala-Phe-Thr-Ile-Pro-Ser-Ile-OH%22+OR+%22TAFTIPSI%22+OR+%22H-TAFTIPSI-OH%22)+AND+peptide&ots=rx0-3VNf4X&sig=3dlo0vqJL7aja692EU3FMp9uyVg TCR clonotypes: molecular determinants of T-cell efficacy against HIV A Lissina, LA Chakrabarti, M Takiguchi - Current opinion in virology, 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1879625716000201

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP46850 H-TAFTIPSI-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".